Finally, the way in which variables are considered (i.e. continuous or binary) is sometimes unclear. For example, Table 1 presents SBP as a continuous variable while it is binary in Table 2 and it is not known in what way when it is an adjustment variable. Why not test the interactions by leaving the variables as continuous? Overall, it would be necessary to justify how the variable is considered and to maintain relative homogeneity across the analyses.
Other issues:
Abstract: In the "results" section, a comma should be added before "whose systolic blood pressure" to avoid misinterpretation. Methods (p.6): 1) Who can access a routine health examination? Is it open to the whole population without restriction? 2) "serious mental disorders" should be more detailed.
3) "Accordingly, a lack of depressive symptoms was defined as a PHQ-9 score of less than 5": this sentence is redundant and in contradiction with "subjects were defined as having no depressive symptoms if their PHQ-9 score was less than 4". Moreover, "normally" is somewhat confusing. p.7: "all baseline characteristics were acquired from the entire population, so no missing data existed in our study": this sentence does not seem to agree with the exclusion of participants who have any missing data for PHQ-9 or baPWV. p.9: "Analyses were also stratified to examine any possible interactions of depressive symptoms and MDD with baPWV and a high baPWV using multiple clinically meaningful cut-off values of baseline parameters: a 10 mmHg increase in SBP; a 5 mmHg increase in DBP […] ": this sentence is not clear since the results only appear for 120/80. If the interaction test has been repeated many times, a multiple testing problem could occur.
Results (p.10):
1) "the prevalence of mild depressive symptoms was 17.0%, the prevalence of moderate to severe depressive symptoms of MDD was 4.0%, and the prevalence of the absence of depressive symptoms (including MDD) was 21.1%": this sentence should be corrected, including for the last figure that is not correct..
2) It is not necessary to write the prevalence of depressive symptoms and p-values for each variable since they are already included in the table. p. 11: "all baseline potential confounding factors were included in the adjusted models unless the variable was used to classify the subgroups": this sentence should rather be placed in the "Methods" part. p.12: Why do Figures 1 and 2 include only these four variables and not all those in Tables 2 and 3? Discussion (p.14):
1) The beginning of the discussion should only present the summary of the results.
2) In the sentence "Subgroup analyses indicated that the abovementioned association was most common in those older than 47 years […]", "most common" should be replaced by a word like "most important" to avoid misinterpretation. p.18: Isn't an unreported limitation the possible lack of power for some analyses? Thus, the absence of interaction for diabetes in Supplemental Table 3 or for hypertension in Table 2 could potentially be due to a lack of power.
REVIEWER
Angelo Scuteri Univesity of Sassari -Italy REVIEW RETURNED 27-Oct-2019
GENERAL COMMENTS
The manuscript deals with an interesting topic but its current version raises several issues. The possible relationship between arterial stiffness and depression has a greater complexity that Authors presented in the current manuscript. A greater BP variability, particularly during night-time, has been reported for MDD (Aging Clinical and Experimental Research 2009; 21: 292-7) and BP variability has some relationship with arterial stiffness (. Int J Cardiol. 2016; 217:92-98) . Depression has been associated with Left Ventricular changes (Nutr Metab Cardiovasc Dis. 2011; 21: 915-21) , that have relationship with arterial stiffness too. Additionally, depression can be a risk factor for onset and progression of cognitive impairment. Arterial stiffness is a risk factor for cognitive impairment (J Alzheimers Dis. 2014; 42 Suppl 4:S401-10). Last, but not least, antidepressant drug classes selectively impact on arterial stiffness ( J Gerontol A Biol Sci Med Sci. 2013; 68: 719-2)
When referring to other studies investigating the relationship between depression and arterial stiffness, it should be clarified which ones measured carotid-femoral PWV and which baPWVas the current study did. The disitinction is far to be only semantic, as it is well known.
The definition of depression should be carefully defined and consitently adopted throughout the manuscript. Questionnaire provide a possible diagnosis of depression and/or the presence of depressive symptoms. Their use for staging the symptoms may be slippery. Terminology like "advanced depressive symptoms "(bottom page 10 and beginning of page 11) should be avoided. Table 1 showed three groups of subjects. However, in the statistical analyses t-test is mentioned. Please, revise and specify which test had been adopted.
It would be interesting to compare not only the occurrence of higher values of baPWV as done at page 12-13, but also of the lower values -see Journal of Hypertension 2018, 36: 2340-2349 for the concept-in subjects with and without MDD.
Minor comments.
-There are repetition in the text. Language needs revision because some terms are inappropriate (see, for instance, the use of "interaction" (page 4, llines 36-38)
VERSION 1 -AUTHOR RESPONSE

Reviewer 1
First MDD was a clinical diagnosis made by face-to-face diagnostic interview according to DSM-IV criteria.
But in our original manuscript, MDD was made from PHQ-9, with 10 as the cut-off value. And this diagnosis of MDD was not clinical accurate though PHQ-9 was used to discriminate MDD in large epidemiologic studies with both high sensitivity and specificity. Therefore, we corrected the inappropriate term "MDD" instead of "moderate to severe depressive symptoms" throughout the revised manuscript. Originally, we explored the relationship between baPWV and PHQ-9 score as continuous variables in the linear regression, but we did not present these results in our former manuscript. So in the corrected version, the analysis between PHQ-9 score and baPWV both as continuous variables were added in the Results (seen in PHQ-9 and baPWV). Even so, most analyses conducted in our study was in subgroups of depressive symptoms according to PHQ-9, as this classification method has good accuracy and consistency, and was widely used in clinical investigations.
Second.
The cut-off value for an elevated cfPWV is 10 m/s according to 2018 ESC/ESH HBP guideline, however, there is no acknowledged cut-off value of baPWV recommended by published guidelines.
Current investigation inferred that there was an increasing trend of the risk of development of CVD across quantiles of baPWV (Hypertension. 2017; 69:1045 -1052 . And we noticed that the upper quartile or quantile of baPWV in different studied population was defined as elevated baPWV in most investigations (Journal of Hypertension 2017, 35:385-391; Arterioscler Thromb Vasc Biol 2012; 32:2321 -2326 J Epidemiol 2014; 24(1):7-14) . So in the same manner, we defined the upper quantile of baPWV as a high baPWV (>1576 cm/s) in the current study, which was appropriate and reasonable. Based on this, we could further elucidate the relationship between depressive symptoms and a high baPWV with another statistical method (logistic regression analysis), which did not seem unnecessary.
Third
Actually, we were unware of the possible role of socioeconomic factors linking depression and CVD, in which arterial stiffness might be involved. Unfortunately, in the current study we did not have the records of socioeconomic factors, so we added this part as one of the study limitations in the discussion section and recommended references were cited.
Finally
In the descriptions of baseline factors in Table 1 , all continuous variables were presented as means and SD, and none was classified. And in subsequent linear regression and logistic regression shown in Table 2 and Table 3 , Figure 1 and Figure 2 , these variables were classified by clinical meaningful cut-off values, seen in Statistical analysis. In subgroup analysis, all baseline variables were adjusted in the linear or logistic regression models unless the variable itself was classified as subgroups in the specific model. We did not test the factors as continuous variables in the interactive analysis cause in this method we could only know whether the interaction existed or not, but in the subgroup analysis,
we could obtain more detailed information, for example, we might only obtain the result that FBG was an interactive factor in the relationship between depressive symptoms and arterial stiffness if analyzed as a continuous variable, but in the subgroup analysis, we clearly found that FBG>6.1 mmol/L aggravated the impact of depressive symptoms on arterial stiffness, which could be more valuable for clinical guidance. The classification methods of the variables were descried in details in the method section, which were referred to previous investigations and relevant to the clinical significance.
Other issues
Abstract A comma was added.
Methods 1) The routine health examination in our hospital is open to anyone who wants to and no special restrictions exist.
2) Serious mental disorders included a range of conditions, such as schizophrenia, bipolar disorder and schizoaffective disorder.
3) We made a mistake defining the group without depressive symptoms and corrected the expression. "Normally" was deleted. p.7: Actually, no missing data existed in the final analysis after we excluded those who have not records of PHQ-9 or baPWV, as well as other exclusion criteria. However, it might be confusing in our original manuscript, so we added "in the final analysis after exclusion" in the Statistical analysis. p.9: We performed the subgroup analyses divided by multiple cut-off values for SBP and DBP in the original analysis. However, we did not provide the results except for SBP at 120 mmHg and DBP at 80 mmHg in the former manuscript mainly because it would take too much content if all provided. And according to our original method, a multiple testing problem might be inevitable. So, recognizing these problems, we decided to divided the subjects by a SBP of 120 mmHg and a DBP of 80 mmHg, which are cut-off values for an optimal blood pressure according to 2018 ESC/ESH HBP guideline. And in this way, the categories of BP were more clinically meaningful, and our manuscript became less distracting, cause the primary purpose was not to test the complex role of BP in the relationship between depression and arterial stiffness. 1) The beginning of the discussion was revised. And the former discussion about the prevalence of depressive symptoms and MDD was deleted.
2) "most common" was replaced by "most important". p.18: Although our study had a relatively large sample size including 1334 participants, a lack of statistical power still remained. As you mentioned, the results of interaction test for subgroup of HBP
in Table 2 and DM in Supplemental table 3 were just not statistically significant. And these were added in the limitation section.
Reviewer 2
1. Unfortunately, we did not have the records of BP variability through ABPM, LVH accessed by echocardiography, examination of cognitive impairment, and treatments with antidepressant drugs, so these potential influencing factors were added and discussed mainly as limitations in the discussion section and recommended references were cited.
2. We noticed that although previous studies indicated that baPWV is in good consistence with cfPWV, the golden standard reflecting arterial stiffness remained cfPWV according to the current guideline.
So as you mentioned, we noted clearly whether baPWV or cfPWV was accessed in certain studies cited in the revised manuscript.
3. We decided to avoid using the diagnosis of MDD which was made from PHQ-9, cause MDD was not verified by diagnostic interviews according to DSM-IV criteria in our study, which was another limitation. And MDD was replaced by moderate to severe depressive symptoms in the revised manuscript. Actually, we selectively divided the population into subgroups by two cut-off values of the PHQ-9, as the presence of depressive symptoms (PHQ-9≥5) and moderate to severe depressive symptoms (PHQ-9≥10). "advanced depressive symptoms" was replaced by "more severe depressive symptoms".
4. In the original statistical analysis section, analysis of variance (ANOVA) for continuous variables and the chi-squared test for categorical variables were used for comparisons between groups (Table 1) . While t-test was not mentioned.
5.
We read your recommended reference and defined a low baPWV with two different cut-offs in a similar manner, less than 10 th or 20 th percentile of baPWV. And the analyses between depressive symptoms, moderate to severe depressive symptoms and a low baPWV in crude and fully adjusted models were listed below. As none of the results were statistical significant and seemed less relevant to the current study, so we did not present these results in the manuscript. But we provided the related results in the following Table A. 6. We revised the expression of the original manuscript. Some inappropriate terms were corrected. Just as a preamble, please leave the reviewers' questions in the answers for ease of reading.
First, the way in which variables are considered (particularly continuous or binary) is always a problem. This results in a mixture of results that are not necessarily consistent and that prevent a clear message from being delivered. A main analysis with only one exposure variable (or even two if really necessary) among PHQ-9, depressive symptoms or moderate to severe depressive symptoms and only one outcome among baPWV or high baPWV would be required. The rest should only be additional analyses to verify the reliability of the main results. This is also true for the other variables.
For example, Table 1 suggests that you consider SBP, DBP and FBG as continuous. In this case, these variables should still be taken as continuous in the models when they are confounding or moderating factors. If you choose a cut-off, you just consider that the effect of these variables is not linear. Or because clinical values seem to you to be of primary importance (but it is important to justify it clearly because the literature is rich in warnings against "the cost of dichotomising continuous variables").
Statistical models also pose a problem in this regard: do you adjust for hypertension when you examine SBP or DBP? What about SBP and DBP when you stratify on hypertension? Same question for diabetes and FBG?
Others issues:
1) A cut-off value of 10 on the PHQ-9 was justified but not the one of 4.
2) You answered that "The routine health examination in our hospital is open to anyone who wants to and no special restrictions exist". However, it is not indicated whether this examination is free or not, which could lead to significant selection bias. Overall, there is little discussion of the external validity of the results.
3) "Serious mental disorders included a range of conditions, such as schizophrenia, bipolar disorder and schizoaffective disorder. ": This information is quite brief. How were the diagnoses reported? Was there a specific psychiatric history search? Similarly, are cardiovascular history only reported by the participant? 4) "If the variable showed significant interaction effect in the association in arterial stiffness either with depressive symptoms or moderate to severe depressive symptoms in the regression models, then it was presented in the forest plots of ORs in Figure  1 and Figure 2 . Therefore, based on the above criterion, only four variables were listed in the final figures. Meanwhile, we also provided the detailed results for other variables in Supplemental First, the way in which variables are considered (particularly continuous or binary) is always a problem. This results in a mixture of results that are not necessarily consistent and that prevent a clear message from being delivered. A main analysis with only one exposure variable (or even two if really necessary) among PHQ-9, depressive symptoms or moderate to severe depressive symptoms and only one outcome among baPWV or high baPWV would be required. The rest should only be additional analyses to verify the reliability of the main results. This is also true for the other variables.
Reply: Thank you for your suggestions and we have made lots of changes in our revised manuscript. Depressive symptoms and moderate to severe depressive were chosen as exposure variables and baPWV (continuous variable) was regarded as outcome variable throughout the manuscript. And the main results of the corrected version remained similar with our previous ones. With regard to SBP, DBP, FBG, BMI and lipid profiles, we selected new grouping methods based on these variables: blood pressure was classified into 3 categories as optimal, normal and high normal, and hypertension; BMI was divided into 3 groups by cut-offs of 24 and 28 kg/m2; a diagnosis of dyslipidemia was obtained based on lipid levels; and a history of diabetes mellitus was presented; and all our classification methods were referred to current related guidelines. We also obtained new age categories by age of 40 and 60 years, and the reason for this grouping method was described in details in the corrected manuscript. In table 1, we presented all continuous variables and related subgroups divided by these variables. And as you raised, the diagnosis of HBP was made from SBP and DBP level, so adjusting for SBP or DBP in stratify on hypertension was not appropriate and the same for other categorical variables. So in the subsequent multivariate linear analysis we performed in new table 2, table 3 and figure 1, adjusted variables only included age categories, gender, smoking status, diabetes mellitus, blood pressure categories, dyslipidemia, and BMI categories, to avoid this problem.
Others issues:
Reply: We provided a more detailed introduction of the PHQ-9 in the method section of the corrected manuscript, including the grouping method of depression based on PHQ-9 score. And we deleted the parameter of depressive symptoms (PHQ-9≥5) which was defined in our previous manuscript.
Reply: The health examination in our hospital was open to anyone who wants to receive a health check-up, but the cost need to be paid by themselves. So we could not deny significant selection bias. This section was added in the limitation of the corrected manuscript, including external validity of our results.
3) "Serious mental disorders included a range of conditions, such as schizophrenia, bipolar disorder and schizoaffective disorder. ": This information is quite brief. How were the diagnoses reported? Was there a specific psychiatric history search? Similarly, are cardiovascular history only reported by the participant?
Reply: The history of serious mental disorders was reported by the participants themselves, and we did not have a specific psychiatric history search. Unfortunately, we did not include the record of cardiovascular history as well. Actually, the participants recruited in our study were relatively healthy, and subjects who have serious mental disorders were less likely to receive a health examination, but general special clinic instead. So it was not surprising that we did not identify a record of serious mental disorder histories during data collection. Besides, we could not exclude the possibility that subjects might hide their former diagnosis of serious mental disorders, as they might consider that it was less relative to a health examination. Even so, we did not consider that our main results could be changed greatly though our exclusion process of serious mental disorders seemed less rigorous. 4) "If the variable showed significant interaction effect in the association in arterial stiffness either with depressive symptoms or moderate to severe depressive symptoms in the regression models, then it was presented in the forest plots of ORs in Figure 1 and Figure 2 . Therefore, based on the above criterion, only four variables were listed in the final figures. Meanwhile, we also provided the detailed results for other variables in Supplemental table 3 and 4". The justification for presenting some variables in the figures but not others does not seem very convincing. In addition, the Supplemental Tables do not present the stratification by smoking or DBP. It would be simpler to present all the main interaction factors (i.e. for the time being those in Tables 2 and 3) in the figures and to leave the "secondary" variables in the supplemental tables.
Reply: The former figures and supplemental tables were deleted in our corrected manuscript.
5) "
In the same manner as in table 2 and table 3": Supplemental tables 1 and 2? Reply: This sentence was deleted, as well as supplemental tables in the corrected manuscript. 6) "however, the results of interaction were non-significant on the borderline.": The end of this sentence should be clearer.
Reply: This sentence was deleted in the corrected manuscript.
VERSION 3 -REVIEW
REVIEWER
Emmanuel Wiernik Inserm, France REVIEW RETURNED 13-Jan-2020
GENERAL COMMENTS
The authors have substantially modified the manuscript, which now appears much clearer. There are still a few points that could be improved: 1) Table 1 : It is not necessary to provide the mean (SD) when the variables are considered categorical. Furthermore, you could add a supplemental table with the same variables but replacing the three categories of depressive symptoms with tertiles of baPWV.
2) Why did you test a trend only in Table 3 and not in the previous analyses? I also suggest sometimes adding "linear" before "trend" to avoid possible confusion.
3) The term 'interactive analysis' should be reworded. 4) Please replace 'gender' by 'sex' to maintain consistency.
5) The last analysis should be further justified, especially since neither age nor sex appeared as significant interaction factors in the previous analysis. Furthermore, it is surprising that this analysis includes a division by SD and does not show the intermediate category of depressive symptoms.
VERSION 3 -AUTHOR RESPONSE
Reviewer 1 1) Table 1 : It is not necessary to provide the mean (SD) when the variables are considered categorical. Furthermore, you could add a supplemental table with the same variables but replacing the three categories of depressive symptoms with tertiles of baPWV. Reply: We deleted the presentation of age and BMI as continuous variables in Table 1 . And as you recommended, we provided the results of baseline characteristics of all subjects according to tertiles of brachial-ankle pulse wave velocity in Supplemental table 1. 2) Why did you test a trend only in Table 3 and not in the previous analyses? I also suggest sometimes adding "linear" before "trend" to avoid possible confusion. Reply: A test for trend in Table 3 seemed unnecessary, so we decided to delete this in Table 3 .
3) The term 'interactive analysis' should be reworded. Reply: The term of 'interactive analysis' was corrected. 4) Please replace 'gender' by 'sex' to maintain consistency. Reply: Gender was replaced by sex.
5) The last analysis should be further justified, especially since neither age nor sex appeared as significant interaction factors in the previous analysis. Furthermore, it is surprising that this analysis includes a division by SD and does not show the intermediate category of depressive symptoms. Reply: Although neither age nor sex had significant interactive effects in the associations between depressive symptoms and baPWV in table 3. However, the Maastricht Study reported that significant associations between depressive symptoms and baPWV existed only in the middle-aged male subgroup (aged 40-60 years) (see reference 20). So we specifically divided our subjects by age and sex in a similar manner to examine whether the above associations remained in our population. And we revised this part in the Discussion Section. We added the results of mild depressive symptoms in the same manner. BaPWV divided by its SD was deleted.
